Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6516
    -0.0020 (-0.31%)
     
  • OIL

    83.12
    +1.77 (+2.18%)
     
  • GOLD

    2,239.90
    +27.20 (+1.23%)
     
  • Bitcoin AUD

    108,561.39
    +3,028.65 (+2.87%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6036
    +0.0006 (+0.10%)
     
  • AUD/NZD

    1.0903
    +0.0023 (+0.21%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,241.96
    -38.89 (-0.21%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,769.97
    +9.89 (+0.02%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     

New Strong Buy Stocks For June 15th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

TEGNA Inc. (TGNA): This media company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.9% over the last 60 days.

TEGNA Inc. Price and Consensus

TEGNA Inc. Price and Consensus
TEGNA Inc. Price and Consensus

TEGNA Inc. price-consensus-chart | TEGNA Inc. Quote

Horace Mann Educators Corporation (HMN): This multiline insurance companyhas seen the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.

Horace Mann Educators Corporation Price and Consensus

Horace Mann Educators Corporation Price and Consensus
Horace Mann Educators Corporation Price and Consensus

Horace Mann Educators Corporation price-consensus-chart | Horace Mann Educators Corporation Quote

ADVERTISEMENT

Aerpio Pharmaceuticals, Inc. (ARPO): This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 86.1% over the last 60 days.

Aerpio Pharmaceuticals, Inc. Price and Consensus

Aerpio Pharmaceuticals, Inc. Price and Consensus
Aerpio Pharmaceuticals, Inc. Price and Consensus

Aerpio Pharmaceuticals, Inc. price-consensus-chart | Aerpio Pharmaceuticals, Inc. Quote

Caesarstone Ltd. (CSTE): This developer and manufacturer of engineered quartz surfaces has seen the Zacks Consensus Estimate for its current year earnings increasing 14.3% over the last 60 days.

Caesarstone Ltd. Price and Consensus

Caesarstone Ltd. Price and Consensus
Caesarstone Ltd. Price and Consensus

Caesarstone Ltd. price-consensus-chart | Caesarstone Ltd. Quote

Ares Commercial Real Estate Corporation (ACRE): This specialty finance company has seen the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Ares Commercial Real Estate Corporation Price and Consensus

Ares Commercial Real Estate Corporation Price and Consensus
Ares Commercial Real Estate Corporation Price and Consensus

Ares Commercial Real Estate Corporation price-consensus-chart | Ares Commercial Real Estate Corporation Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.

Click here for the 6 trades >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
TEGNA Inc. (TGNA) : Free Stock Analysis Report
 
Horace Mann Educators Corporation (HMN) : Free Stock Analysis Report
 
Caesarstone Ltd. (CSTE) : Free Stock Analysis Report
 
Aerpio Pharmaceuticals, Inc. (ARPO) : Free Stock Analysis Report
 
Ares Commercial Real Estate Corporation (ACRE) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research